Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
34.28
+1.82 (5.61%)
At close: Aug 13, 2025, 4:00 PM
34.50
+0.22 (0.64%)
After-hours: Aug 13, 2025, 7:39 PM EDT

Caris Life Sciences Stock Forecast

Stock Price Forecast

According to 6 professional analysts, the 12-month price target for Caris Life Sciences stock ranges from a low of $31 to a high of $42. The average analyst price target of $35.5 forecasts a 3.56% increase in the stock price over the next year.

Price Target: $35.50 (+3.56%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $31 $35.5 $36 $42
Change -9.57% +3.56% +5.02% +22.52%

Analyst Ratings

The average analyst rating for Caris Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Mar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy 000033
Buy 000033
Hold 333300
Sell 000000
Strong Sell 000000
Total 333366

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Guggenheim
Guggenheim
Strong Buy
Maintains
$32$36
Strong Buy Maintains $32$36 +5.02% Aug 13, 2025
Evercore ISI Group
Evercore ISI Group
Buy
Maintains
$33$40
Buy Maintains $33$40 +16.69% Aug 13, 2025
Citigroup
Citigroup
Strong Buy
Maintains
$34$42
Strong Buy Maintains $34$42 +22.52% Aug 13, 2025
Evercore ISI Group
Evercore ISI Group
Buy
Initiates
$33
Buy Initiates $33 -3.73% Jul 15, 2025
TD Cowen
TD Cowen
Strong Buy
Initiates
$32
Strong Buy Initiates $32 -6.65% Jul 14, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
594.32M
from 412.26M
Increased by 44.16%
Revenue Next Year
967.02M
from 594.32M
Increased by 62.71%
EPS This Year
n/a
from -10.66
EPS Next Year
n/a
Fiscal Year FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
258.49M306.13M412.26M594.32M967.02M1.16B
Revenue Growth
-18.43%34.67%44.16%62.71%20.16%
EPS
-11.98-13.24-10.66---
EPS Growth
------
Forward PE
------
No. Analysts
---454
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 637.4M 1.0B 1.3B
Avg 594.3M 967.0M 1.2B
Low 564.8M 889.8M 1.1B

Revenue Growth

Revenue Growth 202520262027
High
54.6%
73.1%
29.3%
Avg
44.2%
62.7%
20.2%
Low
37.0%
49.7%
9.6%

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.